West Virginia Ex Rel. McGraw v. CVS Pharmacy, Inc.

748 F. Supp. 2d 580, 50 Employee Benefits Cas. (BNA) 1561, 2010 U.S. Dist. LEXIS 101127, 2010 WL 3743876
CourtDistrict Court, S.D. West Virginia
DecidedSeptember 21, 2010
DocketCivil Action 2:09-1000
StatusPublished
Cited by7 cases

This text of 748 F. Supp. 2d 580 (West Virginia Ex Rel. McGraw v. CVS Pharmacy, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
West Virginia Ex Rel. McGraw v. CVS Pharmacy, Inc., 748 F. Supp. 2d 580, 50 Employee Benefits Cas. (BNA) 1561, 2010 U.S. Dist. LEXIS 101127, 2010 WL 3743876 (S.D.W. Va. 2010).

Opinion

MEMORANDUM OPINION AND ORDER

JOHN T. COPENHAVER, JR., District Judge.

Pending is the Attorney General’s motion to remand, filed October 13, 2009.

I.

West Virginia law requires pharmacists to “substitute a less expensive equivalent generic name drug” for prescriptions for a brand name drug unless the generic drug is unsuitable for the particular patient. W. Va. Code § 30-5-12b(b). Further, West Virginia law requires that “[a]ll savings in the retail price of the [generic] prescription ... be passed on to the purchaser,” and that “in no event shall such savings be less than the difference in acquisition cost of the brand name product prescribed and the acquisition cost of the substituted product.” Id. at § 30-5-12b(g).

On August 24, 2009, the Attorney General instituted this action in the Circuit Court of Boone County, alleging that defendants “routinely violate this law and do not pass on generic-drug cost-savings to purchasers as the statute requires.” (Compl. ¶ 20). The Attorney General’s complaint contains three counts, discussed more fully infra: 1) violation of West Vir *582 ginia’s generic-drug pricing law, W. Va. Code § 30-5-12b(g); 2) violations of the West Virginia Consumer Credit and Protection Act (“WVCCPA”); and 3) impermissible collection of excess charges under West Virginia Code § 46A-7-111. (IcL at ¶¶ 23-35). The Attorney General seeks injunctive relief, civil penalties, “disgorgement of monies obtained as a result of the generic-drug overcharges,” and other appropriate relief. (Id. at ¶ 1).

Defendants removed on September 10, 2009, asserting three grounds: 1) preemption under the Federal Employees Health Benefits Act (“FEHBA”), 5 U.S.C. § 8902(a) et seq.; 2) preemption and “arising under” jurisdiction based upon the Employee Retirement Income Security Act (“ERISA”), 29 U.S.C. § 1132 et seq.; and 3) the Class Action Fairness Act (“CAFA”), 28 U.S.C. §§ 1332(d), 1453. On October 13, 2009, the Attorney General moved to remand.

II.

A. Governing Standard

“Federal courts are courts of limited jurisdiction. They possess only that power authorized by Constitution and statute, which is not to be expanded by judicial decree.” Kokkonen v. Guardian Life Ins. Co. of Am., 511 U.S. 375, 377, 114 S.Ct. 1673, 128 L.Ed.2d 391 (1994). Title 28 U.S.C. § 1441(a) governs federal removal jurisdiction and provides as follows:

[a]ny civil action brought in a State court of which the district courts of the United States have original jurisdiction, may be removed by the ... defendants ... to the district court of the United States for the district and division embracing the place where such action is pending....

28 U.S.C. § 1441(a).

The burden of establishing removal falls upon the removing party. Mulcahey v. Colum. Organic Chem. Co., 29 F.3d 148, 151 (4th Cir.1994). Our court of appeals has observed time and again that it is obliged to construe removal jurisdiction strictly:

We have noted our obligation “to construe removal jurisdiction strictly because of the ‘significant federalism concerns’ implicated” by it. Maryland Stadium Auth. v. Ellerbe Becket Inc., 407 F.3d 255, 260 (4th Cir.2005) (quoting Mulcahey, 29 F.3d at 151).... Consistent with these principles, we have recognized that state law complaints usually must stay in state court when they assert what appear to be state law claims. See, e.g., Harless v. CSX Hotels, Inc., 389 F.3d 444, 450 (4th Cir. 2004); King [v. Marriott Intern. Inc. ], 337 F.3d 421, 424 (4th Cir.2003); Darcangelo v. Verizon Communications, Inc., 292 F.3d 181, 186 (4th Cir.2002); Cook v. Georgetown Steel Corp., 770 F.2d 1272, 1274 (4th Cir.1985).

Lontz v. Tharp, 413 F.3d 435, 440 (4th Cir.2005). “Any doubts concerning the propriety of removal must be resolved in favor of retained state court jurisdiction.” Marshall v. Manville Sales, Corp., 6 F.3d 229, 232 (4th Cir.1993).

One source of federal jurisdiction is 28 U.S.C. § 1331, which provides “[t]he district courts shall have original jurisdiction of all civil actions arising under the Constitution, laws, or treaties of the United States.” Removal is thus appropriate if the face of the complaint raises a federal question. Lontz, 413 F.3d at 439; Pinney v. Nokia, Inc., 402 F.3d 430, 442 (4th Cir.2005) (noting the well-pleaded complaint rule, namely, “that a plaintiff is the master of the claim, and he may avoid federal jurisdiction by exclusive reliance on state law in drafting his complaint.”) (internal quotation marks omitted).

Respecting ERISA and FEHBA, defendants rely for removal upon two exceptions *583 to the well-pleaded complaint rule. First, defendants assert that FEHBA and ERISA completely preempt the Attorney General’s claims. Second, defendants claim that, even if the Attorney General’s claims are not completely preempted by ERISA, the Grable doctrine justifies removal because the Attorney General’s complaint poses a “necessary and substantial” federal issue, a variant of arising under jurisdiction.

B. The Complete Preemption Doctrine

Under the doctrine of complete preemption, removal is appropriate if “the subject matter of a putative state law claim has been totally subsumed by federal law— such that state law cannot even treat on the subject matter.” Lontz, 413 F.3d at 439-40. When complete preemption exists, federal law provides the exclusive cause of action, and in essence “there is ... no such thing as a state-law claim.” Id. at 440 (quoting Beneficial Nat’l Bank v. Anderson, 539 U.S. 1, 11, 123 S.Ct. 2058, 156 L.Ed.2d 1 (2003)). “The doctrine of complete preemption thus prevents plaintiffs from ‘defeating] removal by omitting to plead necessary federal questions.’ ” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

District of Columbia v. Jth Tax
District of Columbia, 2023
West Virginia ex rel. Morrisey v. Pfizer, Inc.
969 F. Supp. 2d 476 (S.D. West Virginia, 2013)
AU Optronics Corporation v. State of South Carolina
699 F.3d 385 (Fourth Circuit, 2012)
West Virginia ex rel. McGraw v. JPMorgan Chase & Co.
842 F. Supp. 2d 984 (S.D. West Virginia, 2012)
Morris v. Humana Health Plan, Inc.
829 F. Supp. 2d 848 (W.D. Missouri, 2011)
West Virginia Ex Rel. McGraw v. CVS Pharmacy, Inc.
646 F.3d 169 (Fourth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
748 F. Supp. 2d 580, 50 Employee Benefits Cas. (BNA) 1561, 2010 U.S. Dist. LEXIS 101127, 2010 WL 3743876, Counsel Stack Legal Research, https://law.counselstack.com/opinion/west-virginia-ex-rel-mcgraw-v-cvs-pharmacy-inc-wvsd-2010.